Supernus Pharmaceuticals, Inc.

Ensign Peak Advisors, Inc SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

5,190

Value ($000)

258

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	258	0.0%	5,190	12/31/2025
2025 Q3	11/13/2025	719	0.0%	15,040	9/30/2025
2025 Q2	8/12/2025	785	0.0%	24,890	6/30/2025
2025 Q1	5/14/2025	815	0.0%	24,890	3/31/2025
2024 Q4	2/14/2025	900	0.0%	24,890	12/31/2024
2024 Q3	11/14/2024	776	0.0%	24,890	9/30/2024
2024 Q2	8/13/2024	666	0.0%	24,890	6/30/2024
2024 Q1	5/14/2024	849	0.0%	24,890	3/31/2024
2023 Q4	2/14/2024	757	0.0%	26,146	12/31/2023
2023 Q3	11/13/2023	721	0.0%	26,146	9/30/2023
2023 Q2	8/14/2023	786	0.0%	26,146	6/30/2023
2023 Q1	5/15/2023	947	0.0%	26,146	3/31/2023
2022 Q4	2/13/2023	933	0.0%	26,146	12/31/2022
2022 Q3	11/14/2022	655	0.0%	19,346	9/30/2022
2022 Q2	8/12/2022	559	0.0%	19,346	6/30/2022
2022 Q1	5/16/2022	625	0.0%	19,346	3/31/2022
2021 Q4	2/11/2022	564	0.0%	19,346	12/31/2021
2021 Q3	11/12/2021	1,336	0.0%	50,086	9/30/2021
2021 Q2	8/13/2021	1,542	0.0%	50,086	6/30/2021
2021 Q1	5/12/2021	1,311	0.0%	50,086	3/31/2021
2020 Q4	2/12/2021	1,260	0.0%	50,086	12/31/2020
2020 Q3	11/12/2020	1,094	0.0%	52,486	9/30/2020
2020 Q2	8/12/2020	1,247	0.0%	52,486	6/30/2020
2020 Q1	5/11/2020	944	0.0%	52,486	3/31/2020
2019 Q4	2/14/2020	1,224	0.0%	51,586	12/31/2019